With its current trading price of $0.1730 on the OTC, Bioxytran, Inc. ($BIXT) is garnering attention from investors looking for groundbreaking opportunities within the biotech sector. Their unique approach and expanding portfolio make them a compelling candidate for those seeking innovation in healthcare investments.